Literature DB >> 17082306

The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis.

Paolo Zamboni1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17082306      PMCID： PMC1633548          DOI： 10.1177/014107680609901122

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  30 in total

1.  MR venography of multiple sclerosis.

Authors:  I L Tan; R A van Schijndel; P J Pouwels; M A van Walderveen; J R Reichenbach; R A Manoliu; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept.

Authors:  J Wenk; A Foitzik; V Achterberg; A Sabiwalsky; J Dissemond; C Meewes; A Reitz; P Brenneisen; M Wlaschek; W Meyer-Ingold; K Scharffetter-Kochanek
Journal:  J Invest Dermatol       Date:  2001-06       Impact factor: 8.551

Review 3.  Inflammation in multiple sclerosis: the good, the bad, and the complex.

Authors:  Gianvito Martino; Luciano Adorini; Peter Rieckmann; Jan Hillert; Boris Kallmann; Giancarlo Comi; Massimo Filippi
Journal:  Lancet Neurol       Date:  2002-12       Impact factor: 44.182

4.  Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression.

Authors:  Y Herouy; P Mellios; E Bandemir; S Dichmann; P Nockowski; E Schöpf; J Norgauer
Journal:  J Dermatol Sci       Date:  2001-04       Impact factor: 4.563

5.  Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.

Authors:  Bettina Kuenz; Andreas Lutterotti; Michael Khalil; Rainer Ehling; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Journal:  J Neuroimmunol       Date:  2005-10       Impact factor: 3.478

6.  The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis.

Authors:  Paolo Zamboni; Marcello Izzo; Silvia Tognazzo; Sergio Carandina; Massimiliano De Palma; Linda Catozzi; Alberto Caggiati; Gianluigi Scapoli; D Gemmati
Journal:  Free Radic Biol Med       Date:  2006-02-14       Impact factor: 7.376

7.  Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction.

Authors:  M V Gurjar; J Deleon; R V Sharma; R C Bhalla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-12       Impact factor: 4.733

8.  Iron-deficient mice fail to develop autoimmune encephalomyelitis.

Authors:  Sharon M Grant; Jason A Wiesinger; John L Beard; Margherita T Cantorna
Journal:  J Nutr       Date:  2003-08       Impact factor: 4.798

9.  Iron and 8-isoprostane levels in acute and chronic wounds.

Authors:  Sim Yeoh-Ellerton; Michael C Stacey
Journal:  J Invest Dermatol       Date:  2003-10       Impact factor: 8.551

10.  Urine hemosiderin: a novel marker to assess the severity of chronic venous disease.

Authors:  Paolo Zamboni; Marcello Izzo; Luisella Fogato; Sergio Carandina; Vincenzo Lanzara
Journal:  J Vasc Surg       Date:  2003-01       Impact factor: 4.268
View more
  71 in total

1.  β-Carotene can reverse dysregulation of iron protein in an in vitro model of inflammation.

Authors:  Oksana Katz; Ram Reifen; Aaron Lerner
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective.

Authors:  Michael D Dake; Robert Zivadinov; E Mark Haacke
Journal:  Funct Neurol       Date:  2011 Oct-Dec

3.  Incidence of extrinsic compression of the internal jugular vein in unselected patients undergoing CT angiography.

Authors:  M V Jayaraman; J L Boxerman; L M Davis; R A Haas; J M Rogg
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

Review 4.  CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.

Authors:  Claudio Baracchini; José M Valdueza; Massimo Del Sette; Galina Baltgaile; Eva Bartels; Natan M Bornstein; Juergen Klingelhoefer; Carlos Molina; Kurt Niederkorn; Mario Siebler; Matthias Sturzenegger; Bernd E Ringelstein; David Russell; Laszlo Csiba
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

5.  Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.

Authors:  Alessandra Ferlini; Matteo Bovolenta; Marcella Neri; Francesca Gualandi; Alessandra Balboni; Anton Yuryev; Fabrizio Salvi; Donato Gemmati; Alberto Liboni; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

6.  ["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients].

Authors:  C Krogias; A Schröder; H Wiendl; R Hohlfeld; R Gold
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

Review 7.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

8.  Comparison of MR and contrast venography of the cervical venous system in multiple sclerosis.

Authors:  G Zaharchuk; N J Fischbein; J Rosenberg; R J Herfkens; M D Dake
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

Review 9.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

10.  Chronic cerebrospinal venous insufficiency in patients with Ménière's disease.

Authors:  R Filipo; F Ciciarello; G Attanasio; P Mancini; E Covelli; L Agati; F Fedele; M Viccaro
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-07       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.